WESTLAKE VILLAGE, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno ...
ZORYVE foam 0.3% shows significant efficacy for scalp and body psoriasis, with FDA review anticipated by May 2025. Arcutis Biotherapeutics, Inc. announced positive results from a pivotal Phase 3 study ...
NEWPORT BEACH, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC. (NASDAQ: ELAB), a pioneering force in medical aesthetics, is excited to announce the introduction of the Elevai S-Series™ ...
LONG BEACH, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (NASDAQ: SKIN), home to flagship brand Hydrafacial™, today announced that findings from two new clinical studies evaluating ...
New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen Scalp Screen Dry Shampoo SPF 45+ Sunscreen Named a ...
(MENAFN- GlobeNewsWire - Nasdaq) HydraScalp with Keravive study highlights improvements in scalp hydration and overall scalp quality following a single treatment Hydrafacial study shows improvements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results